A Study of Baricitinib (LY3009104) in Healthy Chinese Participants
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety and tolerability of the study
drug known as baricitinib in healthy Chinese participants. The study will measure how the
body absorbs, breaks down and gets rid of baricitinib. The study will last about 20 days, not
including screening. This study is for research purposes only, and is not intended to treat
any medical condition.